Back

Updated on 01/09/2026

LIPRA 25 mg

Clomipramine hydrochloride

Treatment of depression, obsessive-compulsive disorder, and nocturnal enuresis

Fabriqué en France

  • Packaging:

    30 film-coated tablets

  • CONTRAINDICATIONS:

    Never take LIPRA in the following cases:

    • Known allergy to clomipramine or any of the other ingredients in this medication (see “COMPOSITION” section).

    • Known risk of angle-closure glaucoma (increased pressure inside the eye).

    • Difficulty urinating due to prostate problems or other causes.

    • Recent myocardial infarction.

    • Concomitant use with another antidepressant (iproniazid, nialamide) or sultopride.

    This medication SHOULD GENERALLY NOT BE USED in the following cases, unless otherwise advised by your doctor:

    • In combination with alcohol or medications containing alcohol.

    • Treatment with another antidepressant (moclobemide, toloxatone) or with medications that affect the cardiovascular system (clonidine, guanfacine, and injectable forms: epinephrine, norepinephrine, dopamine), linezolid (an antibiotic).

Report

Do you wish to make a report?

In accordance with legal and regulatory obligations governing health and safety, you can report any adverse event (medicinal or cosmetic) or suspected quality defect related to the use of one of our products.

This information is crucial for the ongoing evaluation of our safety profile. Please submit your report: directly to our monitoring department via the contact form for medications; and/or via our telephone number +33 (0)3 86 20 21 64.